Previous 10 | Next 10 |
2023-10-16 14:48:23 ET The market is in very good shape, said Hennessy Funds’ chief market strategist Neil Hennessy. In a CNBC interview on Monday, he pointed out that all three indexes are up. ( DJI ) up 13.07%, compared to last year. ( SP500 ) up 19.13%, compa...
2023-10-15 22:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Equities experienced a...
2023-10-15 16:33:45 ET Piper Sandler said it sees GLP-1 drugs as having only a limited impact on the market for devices to treat type 2 diabetes and virtually no impact on those to treat type 1, at least for the next several years. In a note, Piper said it saw the recent sell-off in dia...
2023-10-15 04:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp rise in yields...
2023-10-12 12:05:15 ET Summary FDA announcement of the creation of a Digital Health Advisory Committee causes a 7.2% decline in the iShares U.S. Medical Devices ETF. Digital health industry shows immense potential, driven by consumer-driven healthcare, remote monitoring, and teleh...
2023-10-12 06:58:38 ET More on the markets Depression Alert: Why The Shrinking Money Supply Spells Trouble For SPY SPY: An Early Contrarian Opportunity (Technical Analysis, Rating Upgrade) Something Will Break Soon Seeking Alpha's quant ratings recommend tech...
2023-10-11 10:59:46 ET More on iShares U.S. Medical Devices ETF IHI: Too Expensive Considering Long-Term Rate Uncertainty JPMorgan says time to buy MedTech based on past Seeking Alpha’s Quant Rating on iShares U.S. Medical Devices ETF Dividend scorecar...
2023-10-10 13:30:19 ET Summary I am returning from a break from writing articles to pursue the CFA designation, now I will focus on fixing my portfolio. The main issues with my portfolio are balance and the need for a review of current investments based on the 7 most important tre...
2023-10-09 08:51:04 ET More on Best Buy, DexCom Why DexCom May Be Up To 40% Undervalued How Juicy Is Best Buy's 5% Yield? Best Buy: Remains A Hold Amid Mixed Q2 Results And Industry Headwinds Best Buy sets holiday strategy with tech upgrade cycle working in i...
Dexcom G7 is available for people with all types of diabetes ages two years and older, giving more Canadians than ever access to a simple, accurate 1 and effective diabetes management solution Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (r...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...